摘要：SummaryPrecise regulation of innate immunity is crucial for development of appropriate host immunity against microbial infections and maintenance of immune homeostasis. MicroRNAs are small non-coding RNAs, post-transcriptional regulator of multiple genes, and act as a rheostat for protein expression. Here, we identified microRNA-30e-5p induced by hepatitis B virus and other viruses that act as a master regulator for innate immunity. Moreover, pegylated interferons treatment of patients with HBV for viral reduction also reduces miRNA. Additionally, we have also shown the immuno-pathological effects of miR-30e in patients with systemic lupus erythematosus (SLE) and mouse model. Mechanistically, miR-30e targets multiple negative regulators of innate immune signaling and enhances immune responses. Furthermore, sequestering of miR-30e in patients with SLE and mouse model significantly reduces type-I interferon and pro-inflammatory cytokines. Collectively, our study demonstrates the novel role of miR-30e in innate immunity and its prognostic and therapeutic potential in infectious and autoimmune diseases.Graphical AbstractDisplay OmittedHighlights•Pathogen (virus)/damage-associated molecular patterns induce microRNA-30e-5p•MiRNA-30e-5p regulates negative regulators of innate immune signaling pathways•Enhanced expression of miRNA-30e-5p may result in systemic lupus erythematosus (SLE)•Locked nucleic acid (LNA) inhibits miRNA-30e-5p and reduces molecular signatures of SLEImmunology; Virology
